cureus – Retraction Watch

After saying it would retract an article, Cureus changed its mind

Karen Rech, a hematopathologist at Mayo Clinic in Rochester, Minn., was reading a case report about a rare disease when she recognized the patient.

Although the authors of the paper were affiliated with the University of North Dakota School of Medicine and Health Sciences in Fargo, the patient in the report had gone to Mayo for care, and Rech had made the pathology diagnosis. But the article, “A Diagnostic Dilemma and Classification Conundrum: Atypical Histiocytic Neoplasm Presenting as a Calvarial Mass,” published in Cureus in February, didn’t mention or credit Rech or her colleagues.

“The ability to make such a unique diagnosis is a direct result of my translational research in histiocytic neoplasms,” Rech wrote in an email to the journal in April. After she made the pathology diagnosis, a hematologist colleague saw the patient, and a group of specialists discussed the case and came to a consensus diagnosis.

Web of Science puts mega-journals Cureus and Heliyon on hold

Web of Science, Clarivate’s influential database of abstracts and citations, has paused indexation of new content from the open-access journals Heliyon and Cureus, apparently due to concerns about the quality of their articles.

Indexation in WoS or Scopus, another major bibliometric database owned by Elsevier, has become an important stamp of approval for scholarly publications worldwide and can make or break a journal.

WoS is “making a big call here, taking aim at two of the mega-journals that have grown massively in recent years,” said Nick Wise, a scientific sleuth and a researcher at the University of Cambridge in the United Kingdom. “WoS appears to be one of the only organisations with the power to compel big publishers to act. I don’t think that’s a sign of a healthy academic publishing system, but it’s how things are currently.”

Journal retracts article for plagiarized images after trying to gag researcher who complained

The journal Cureus retracted an article for plagiarized images after questioning the motives of the researcher who said her images were taken.

The researcher, who asked to remain anonymous, first emailed Cureus, an open-access journal Springer Nature acquired in 2022, on August 1. She said she noticed images in the October 2023 paper, “Pediatric Acute Dacryocystitis and Orbital Cellulitis With Concurrent COVID-19 Infection: A Case Report,” came from a lecture she posted online and later removed.

“The images used in this article were edited and presented under a fabricated clinical scenario” and had been used without her permission, the researcher wrote in an email seen by Retraction Watch. She requested the journal retract the article. She also provided what she said were her original images, which were replicated in Figure 1 of the paper, and copied the corresponding author of the article.

Journal retracts redundant case study of same patient from different authors

Cureus has retracted a 2024 case study after learning it had published a piece about the identical patient, by authors from the same institution, just months earlier.

The paper, “Lipoma Growing on the Back for 26 Years: A Bizarre Case Report,” was published March 26 and retracted June 17. Three of the four authors are affiliated with Datta Meghe Institute of Higher Education and Research, in Wardha, India. The corresponding author, Samiksha V. Gupta, was a medical student at the institution but has since received his degree.

The notice states:

Cureus retracts paper for plagiarism following Retraction Watch inquiries

The journal Cureus has retracted a 2022 paper on cancer and the environment just weeks after Retraction Watch raised questions about apparent plagiarism in the article.

As we reported in early April, the paper, “Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioral and Environmental Risk Factors”, had a bit of a twinsies thing going with a 2005 article in The Lancet – sharing a title, figures, and wording that “follows the Lancet one on a sentence-by-sentence level while using tortured phrases,” according to the anonymous tipster who informed us of the issue.

The April 19 retraction notice states:

Cureus reviewing paper alleged to plagiarize Lancet article

A 2022 paper in Cureus on causes of cancer around the world is under investigation by the journal following inquiries by Retraction Watch prompted by a reader’s email.

The paper, “Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioral and Environmental Risk Factors,” shares a title and figures with a 2005 paper in The Lancet. It also “follows the Lancet one on a sentence-by-sentence level while using tortured phrases,” an anonymous tipster told us.

As we’ve noted elsewhere in a report on the team that developed the phrase, “Tortured phrases are what happens to words that get translated from English into a foreign language, then back to English — perhaps by a computer trying to generate a scholarly publication for a group of unscrupulous authors.”

Journal blacklists doctor in Pakistan ‘out of an abundance of caution’

Following an investigation into possible paper mill activities, the journal Cureus has barred a doctor in Pakistan from publishing more papers “out of an abundance of caution,” Retraction Watch has learned.

The journal investigated Satish Kumar, an internist at Shaheed Mohtarma Benazir Bhutto Medical College in Karachi, after a tipster accused him of selling authorship of scientific papers to scientists who did not participate in the research.

The tipster, who wishes to remain anonymous to avoid backlash from the authors of these papers, sent Cureus WhatsApp messages from a group called “research Match Residency.” There, a user named ”SSS” sent paper titles and offered author slots on manuscripts. Many of the articles were slated for publication in Cureus.

Paper claiming ‘extensive’ harms of COVID-19 vaccines to be retracted

A journal is retracting a paper on the purported harms of vaccines against COVID-19 written in part by authors who have had similar work retracted before.

The article, “COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign,” appeared late last month in Cureus, which used to be a stand-alone journal but is now owned by Springer Nature. (It has appeared frequently in these pages.)

Graham Parker, Director of Publishing and Customer Success at Cureus, told Retraction Watch:

I can confirm we will be retracting it by the end of the week, as we have provided the authors with a deadline to reply and indicate whether they agree or disagree with the retraction.

The senior author on the work was Peter McCullough, a cardiologist at the Institute of Pure and Applied Knowledge who lost his board certification after the American Board of Internal Medicine found he had “provided false or inaccurate medical information to the public.”

Journal retracts more than 50 studies from Saudi Arabia for faked authorship

The journal Cureus has retracted 56 papers nearly two years after it first began to suspect the works were of dubious lineage.

Cureus – an open access journal founded in 2009 and acquired by Springer Nature in 2022 – slapped 55 of the papers with expressions of concern in April 2022. At that time, at least one author said they didn’t know anything about the work and Cureus noted the “articles were submitted and subsequently published purportedly as an effort coordinated by Imam Abdulrahman Bin Faisal University to ensure all medical interns publish at least one peer-reviewed article in order to qualify for enrollment in a postgraduate residency program as stipulated by The Saudi Commission for Health Specialties (SCFHS).”

At the time, Cureus’ founding editor in chief John Adler told us “The investigation has been frustratingly slow due to the relative unresponsiveness of Saudi gov officials.” Apparently, that remained the case. This week, the journal retracted 56 studies. All of the retraction notices read the same way:

Cornell food marketing researcher who retired after misconduct finding is publishing again

Brian Wansink, the food marketing researcher who retired from Cornell in 2019 after the university found that he had committed academic misconduct, has published two new papers.

The articles, in Cureus and the International Journal of Community Medicine and Public Health, appear to use data that are at least a decade old. Wansink’s only coauthor on the papers is Audrey Wansink, a high school student and, evidently, his daughter. Brian Wansink did not respond to Retraction Watch’s request for comment.

Wansink’s work came under scrutiny beginning in 2016, after he published a blog post that described research practices that sounded like p-hacking to some readers. Other researchers started reviewing his published papers and found many issues.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: